3,290
Views
32
CrossRef citations to date
0
Altmetric
Research Articles

Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach

, , , , , , & show all
Pages 4701-4714 | Received 17 May 2020, Accepted 03 Jun 2020, Published online: 22 Jun 2020

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.